Dicerna Pharmaceuticals Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Dicerna Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Dicerna Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Dicerna Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 2.39 | |
| Fifty Two Week Low | 19.06 | |
| Target High Price | 38.25 | |
| Fifty Two Week High | 40.14 | |
| Target Low Price | 26.00 |
Dicerna |
Dicerna Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Dicerna Pharmaceuticals on September 14, 2024 and sell it today you would earn a total of 100.00 from holding Dicerna Pharmaceuticals or generate -100.0% return on investment over 90 days. Dicerna Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Dicerna, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Dicerna Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dicerna Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dicerna Pharmaceuticals, and traders can use it to determine the average amount a Dicerna Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DRNA |
Based on monthly moving average Dicerna Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dicerna Pharmaceuticals by adding Dicerna Pharmaceuticals to a well-diversified portfolio.
Dicerna Pharmaceuticals Fundamentals Growth
Dicerna Stock prices reflect investors' perceptions of the future prospects and financial health of Dicerna Pharmaceuticals, and Dicerna Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dicerna Stock performance.
| Return On Equity | -95.22 | |||
| Return On Asset | -10.43 | |||
| Profit Margin | (64.53) % | |||
| Operating Margin | (62.88) % | |||
| Current Valuation | 2.48 B | |||
| Shares Outstanding | 77.91 M | |||
| Price To Earning | (1.58) X | |||
| Price To Book | 27.64 X | |||
| Price To Sales | 15.44 X | |||
| Revenue | 192.85 M | |||
| EBITDA | (116.73 M) | |||
| Cash And Equivalents | 565.51 M | |||
| Cash Per Share | 7.26 X | |||
| Total Debt | 64.42 M | |||
| Debt To Equity | 0.60 % | |||
| Book Value Per Share | 1.38 X | |||
| Cash Flow From Operations | 21.05 M | |||
| Earnings Per Share | (1.63) X | |||
| Total Asset | 62.95 M | |||
| Retained Earnings | (539.14 M) | |||
| Current Asset | 59.38 M | |||
| Current Liabilities | 9.82 M | |||
Things to note about Dicerna Pharmaceuticals performance evaluation
Checking the ongoing alerts about Dicerna Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dicerna Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dicerna Pharmaceuticals is not yet fully synchronised with the market data | |
| Dicerna Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Dicerna Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 192.85 M. Net Loss for the year was (124.44 M) with loss before overhead, payroll, taxes, and interest of (41.08 M). | |
| Over 89.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Dicerna Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dicerna Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Dicerna Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dicerna Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dicerna Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dicerna Pharmaceuticals' stock. These opinions can provide insight into Dicerna Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Dicerna Stock
If you are still planning to invest in Dicerna Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Dicerna Pharmaceuticals' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |